Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY1R | P25929 | 1/20 | 0.69 |
| ▸ | NPY2R | P49146 | 1/20 | 0.69 |
| ▸ | NPY4R | P50391 | 1/20 | 0.69 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.69 |
| ▸ | CALCR | P30988 | 3/20 | 0.65 |
| ▸ | GLP1R | P43220 | 11/20 | 0.65 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.62 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30658305 | 0.95 | NPY1R (0.67) | NPY1RNPY2RNPY4RNPY5RCALCR | |
| SCHEMBL30658324 | 0.93 | NPY2R (0.71) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL31182602 | 0.93 | CALCR (0.64) | NPY1RNPY2RNPY4RNPY5RCALCR | |
| SCHEMBL31073551 | 0.92 | NPY1R (0.69) | NPY1RNPY2RNPY4RNPY5RCALCR | |
| SCHEMBL30658310 | 0.92 | CALCR (0.63) | NPY1RNPY2RNPY4RNPY5RCALCR | |
| SCHEMBL30607270 | 0.92 | NPY2R (0.66) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL30658391 | 0.92 | NPY2R (0.70) | NPY1RNPY2RNPY4RNPY5RCALCR | |
| SCHEMBL31182986 | 0.91 | PTH1R (0.68) | NPY1RNPY2RNPY4RNPY5RGLP1R | |
| SCHEMBL31182980 | 0.91 | NPY1R (0.65) | NPY1RNPY2RNPY4RNPY5RCALCR | |
| SCHEMBL30658195 | 0.91 | CALCR (0.65) | NPY1RNPY2RNPY4RNPY5RCALCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11753627-B2 | Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-09-12 | — | — | US | disclosed |